PFG Investments LLC acquired a new position in shares of Kineta, Inc. (NASDAQ:KA – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 326,988 shares of the company’s stock, valued at approximately $174,000. PFG Investments LLC owned approximately 2.67% of Kineta at the end of the most recent reporting period.
Kineta Stock Performance
NASDAQ:KA opened at $0.77 on Friday. The stock has a market capitalization of $9.42 million, a P/E ratio of -0.51 and a beta of 0.46. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.05. Kineta, Inc. has a 1 year low of $0.33 and a 1 year high of $5.39. The firm has a 50 day moving average of $0.66 and a 200-day moving average of $0.60.
Kineta (NASDAQ:KA – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.20) earnings per share (EPS) for the quarter. As a group, sell-side analysts anticipate that Kineta, Inc. will post -1.41 EPS for the current fiscal year.
Kineta Profile
Kineta, Inc is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug.
Read More
- Five stocks we like better than Kineta
- How to Most Effectively Use the MarketBeat Earnings Screener
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- 5 Top Rated Dividend Stocks to Consider
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for Kineta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kineta and related companies with MarketBeat.com's FREE daily email newsletter.